From the Desk of the CEO

WASHINGTON, DC—The American Pharmacists Association (APhA) announced today that its 2024–2025 Executive Postgraduate Training cohort has been finalized.

Washington, DC – The American Pharmacists Association (APhA) appreciates the collaborative support announced by the Drug Enforcement Administration (DEA), the U.S. Department of Health and Human Services (HHS), and Substance Abuse and Mental Health Services Administration (SAMHSA) to break down access barriers to medications for opioid use disorder (MOUD).

Washington, DC – The National Association of Chain Drug Stores, the National Community Pharmacists Association, FMI – The Food Industry Association, the National Grocers Association, the American Pharmacists Association, the National Association of Specialty Pharmacy, and the National Alliance of State Pharmacy Associations issued the following statement today.

(March 1, 2024 – Washington, D.C.) As the Change Healthcare outage is now in its second week, the pharmacy community continues to be challenged and frustrated by the significant impact this has on pharmacies, pharmacy teams, and patients—from both an access to care and an economic perspective. Pharmacies are struggling or—in some cases—unable to process prescription claims, some have not received e-prescriptions for a full week, and many cannot process manufacturer patient assistance copay cards, which patients rely on.

WASHINGTON, DC — The American Pharmacists Association (APhA) and the Contraceptive Access Initiative (CAI) are delighted to announce progress on a path forward for increasing access to hormonal contraceptives at pharmacies. This follows the successful conclusion of the "Accessible Consumer Choices: Shaping the Future of Contraceptive Care at Pharmacies Summit," held at APhA Headquarters on February 28, 2024.